SunTrust Robinson Humphrey Starts OncoMed Pharmaceuticals (OMED) at Buy
Tweet
Share
E-mailGet Alerts OMED Hot Sheet
Price: $0.89 --0%
Rating Summary:
1 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 55
Rating Summary:
1 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 55
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on OncoMed Pharmaceuticals (NASDAQ: OMED) with a Buy rating and a price target of $16.00.
For an analyst ratings summary and ratings history on OncoMed Pharmaceuticals click here. For more ratings news on OncoMed Pharmaceuticals click here.
Shares of OncoMed Pharmaceuticals closed at $7.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts Jersey Mike's Subs (JMKE) at Equal Weight
- BTIG Starts Jersey Mike's Subs (JMKE) at Buy
- Wells Fargo Starts Fortune Brands (FBIN) at Overweight, 'Catch Up Potential Could Prove Attractive (with Caveats)'
Create E-mail Alert Related Categories
New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
